The global Cell Gene Overexpression Service market  size is set to grow from  US$ 839 million in 2024 to US$ 1103 million in 2030; it is expected to grow at a CAGR of 4.7% from 2024 to 2030.

Global Cell Gene Overexpression Service Market Growth and Outlook 2025-31

The global Cell Gene Overexpression Service market size is predicted to grow from US$ 839 million in 2024 to US$ 1103 million in 2030; it is expected to grow at a CAGR of 4.7% from 2024 to 2030. Gene overexpression is the process of cloning the target gene CDS into a corresponding plasmid or viral vector, and utilizing regulatory elements constructed on the vector backbone to enable the gene to be transcribed and translated in large quantities under artificially controlled conditions, thereby achieving overexpression of the target gene. United States market for Cell Gene Overexpression Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Cell Gene Overexpression Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Cell Gene Overexpression Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Cell Gene Overexpression Service players cover Jiangyuan Biotechnology, Brain Case, Yuanjing Biology, OBiO Technology, GENE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. LPI (LP Information) newest research report, the Cell Gene Overexpression Service Industry Forecast looks at past sales and reviews total world Cell Gene Overexpression Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Cell Gene Overexpression Service sales for 2024 through 2030. With Cell Gene Overexpression Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Gene Overexpression Service industry. This Insight Report provides a comprehensive analysis of the global Cell Gene Overexpression Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Gene Overexpression Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Cell Gene Overexpression Service market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Gene Overexpression Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Gene Overexpression Service. This report presents a comprehensive overview, market shares, and growth opportunities of Cell Gene Overexpression Service market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Transient Overexpression &nbsp;&nbsp;&nbsp; Stable Overexpression Segmentation by Application: &nbsp;&nbsp;&nbsp; Biomedicine &nbsp;&nbsp;&nbsp; Functional Genomics &nbsp;&nbsp;&nbsp; Protein Engineering &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Jiangyuan Biotechnology &nbsp;&nbsp;&nbsp; Brain Case &nbsp;&nbsp;&nbsp; Yuanjing Biology &nbsp;&nbsp;&nbsp; OBiO Technology &nbsp;&nbsp;&nbsp; GENE &nbsp;&nbsp;&nbsp; Brainvta &nbsp;&nbsp;&nbsp; VectorBuilder &nbsp;&nbsp;&nbsp; Boyuan Group &nbsp;&nbsp;&nbsp; Horizo??n &nbsp;&nbsp;&nbsp; Creative Biogene &nbsp;&nbsp;&nbsp; ACROBiosystems &nbsp;&nbsp;&nbsp; Cayegn &nbsp;&nbsp;&nbsp; Creative Bioarray &nbsp;&nbsp;&nbsp; CUSABIO &nbsp;&nbsp;&nbsp; SBI

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Cell Gene Overexpression Service Market Size 2019-2030 &nbsp;2.1.2 Cell Gene Overexpression Service Market Size CAGR by Region (2019 VS 2023 VS 2030) &nbsp;2.1.3 World Current & Future Analysis for Cell Gene Overexpression Service by Country/Region, 2019, 2023 & 2030 &nbsp;2.2 Cell Gene Overexpression Service Segment by Type &nbsp;2.2.1 Transient Overexpression &nbsp;2.2.2 Stable Overexpression &nbsp;2.3 Cell Gene Overexpression Service Market Size by Type &nbsp;2.3.1 Cell Gene Overexpression Service Market Size CAGR by Type (2019 VS 2023 VS 2030) &nbsp;2.3.2 Global Cell Gene Overexpression Service Market Size Market Share by Type (2019-2024) &nbsp;2.4 Cell Gene Overexpression Service Segment by Application &nbsp;2.4.1 Biomedicine &nbsp;2.4.2 Functional Genomics &nbsp;2.4.3 Protein Engineering &nbsp;2.4.4 Other &nbsp;2.5 Cell Gene Overexpression Service Market Size by Application &nbsp;2.5.1 Cell Gene Overexpression Service Market Size CAGR by Application (2019 VS 2023 VS 2030) &nbsp;2.5.2 Global Cell Gene Overexpression Service Market Size Market Share by Application (2019-2024) 3 Cell Gene Overexpression Service Market Size by Player &nbsp;3.1 Cell Gene Overexpression Service Market Size Market Share by Player &nbsp;3.1.1 Global Cell Gene Overexpression Service Revenue by Player (2019-2024) &nbsp;3.1.2 Global Cell Gene Overexpression Service Revenue Market Share by Player (2019-2024) &nbsp;3.2 Global Cell Gene Overexpression Service Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Cell Gene Overexpression Service by Region &nbsp;4.1 Cell Gene Overexpression Service Market Size by Region (2019-2024) &nbsp;4.2 Global Cell Gene Overexpression Service Annual Revenue by Country/Region (2019-2024) &nbsp;4.3 Americas Cell Gene Overexpression Service Market Size Growth (2019-2024) &nbsp;4.4 APAC Cell Gene Overexpression Service Market Size Growth (2019-2024) &nbsp;4.5 Europe Cell Gene Overexpression Service Market Size Growth (2019-2024) &nbsp;4.6 Middle East & Africa Cell Gene Overexpression Service Market Size Growth (2019-2024) 5 Americas &nbsp;5.1 Americas Cell Gene Overexpression Service Market Size by Country (2019-2024) &nbsp;5.2 Americas Cell Gene Overexpression Service Market Size by Type (2019-2024) &nbsp;5.3 Americas Cell Gene Overexpression Service Market Size by Application (2019-2024) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Cell Gene Overexpression Service Market Size by Region (2019-2024) &nbsp;6.2 APAC Cell Gene Overexpression Service Market Size by Type (2019-2024) &nbsp;6.3 APAC Cell Gene Overexpression Service Market Size by Application (2019-2024) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Cell Gene Overexpression Service Market Size by Country (2019-2024) &nbsp;7.2 Europe Cell Gene Overexpression Service Market Size by Type (2019-2024) &nbsp;7.3 Europe Cell Gene Overexpression Service Market Size by Application (2019-2024) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Cell Gene Overexpression Service by Region (2019-2024) &nbsp;8.2 Middle East & Africa Cell Gene Overexpression Service Market Size by Type (2019-2024) &nbsp;8.3 Middle East & Africa Cell Gene Overexpression Service Market Size by Application (2019-2024) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Cell Gene Overexpression Service Market Forecast &nbsp;10.1 Global Cell Gene Overexpression Service Forecast by Region (2025-2030) &nbsp;10.1.1 Global Cell Gene Overexpression Service Forecast by Region (2025-2030) &nbsp;10.1.2 Americas Cell Gene Overexpression Service Forecast &nbsp;10.1.3 APAC Cell Gene Overexpression Service Forecast &nbsp;10.1.4 Europe Cell Gene Overexpression Service Forecast &nbsp;10.1.5 Middle East & Africa Cell Gene Overexpression Service Forecast &nbsp;10.2 Americas Cell Gene Overexpression Service Forecast by Country (2025-2030) &nbsp;10.2.1 United States Market Cell Gene Overexpression Service Forecast &nbsp;10.2.2 Canada Market Cell Gene Overexpression Service Forecast &nbsp;10.2.3 Mexico Market Cell Gene Overexpression Service Forecast &nbsp;10.2.4 Brazil Market Cell Gene Overexpression Service Forecast &nbsp;10.3 APAC Cell Gene Overexpression Service Forecast by Region (2025-2030) &nbsp;10.3.1 China Cell Gene Overexpression Service Market Forecast &nbsp;10.3.2 Japan Market Cell Gene Overexpression Service Forecast &nbsp;10.3.3 Korea Market Cell Gene Overexpression Service Forecast &nbsp;10.3.4 Southeast Asia Market Cell Gene Overexpression Service Forecast &nbsp;10.3.5 India Market Cell Gene Overexpression Service Forecast &nbsp;10.3.6 Australia Market Cell Gene Overexpression Service Forecast &nbsp;10.4 Europe Cell Gene Overexpression Service Forecast by Country (2025-2030) &nbsp;10.4.1 Germany Market Cell Gene Overexpression Service Forecast &nbsp;10.4.2 France Market Cell Gene Overexpression Service Forecast &nbsp;10.4.3 UK Market Cell Gene Overexpression Service Forecast &nbsp;10.4.4 Italy Market Cell Gene Overexpression Service Forecast &nbsp;10.4.5 Russia Market Cell Gene Overexpression Service Forecast &nbsp;10.5 Middle East & Africa Cell Gene Overexpression Service Forecast by Region (2025-2030) &nbsp;10.5.1 Egypt Market Cell Gene Overexpression Service Forecast &nbsp;10.5.2 South Africa Market Cell Gene Overexpression Service Forecast &nbsp;10.5.3 Israel Market Cell Gene Overexpression Service Forecast &nbsp;10.5.4 Turkey Market Cell Gene Overexpression Service Forecast &nbsp;10.6 Global Cell Gene Overexpression Service Forecast by Type (2025-2030) &nbsp;10.7 Global Cell Gene Overexpression Service Forecast by Application (2025-2030) &nbsp;10.7.1 GCC Countries Market Cell Gene Overexpression Service Forecast 11 Key Players Analysis &nbsp;11.1 Jiangyuan Biotechnology &nbsp;11.1.1 Jiangyuan Biotechnology Company Information &nbsp;11.1.2 Jiangyuan Biotechnology Cell Gene Overexpression Service Product Offered &nbsp;11.1.3 Jiangyuan Biotechnology Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.1.4 Jiangyuan Biotechnology Main Business Overview &nbsp;11.1.5 Jiangyuan Biotechnology Latest Developments &nbsp;11.2 Brain Case &nbsp;11.2.1 Brain Case Company Information &nbsp;11.2.2 Brain Case Cell Gene Overexpression Service Product Offered &nbsp;11.2.3 Brain Case Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.2.4 Brain Case Main Business Overview &nbsp;11.2.5 Brain Case Latest Developments &nbsp;11.3 Yuanjing Biology &nbsp;11.3.1 Yuanjing Biology Company Information &nbsp;11.3.2 Yuanjing Biology Cell Gene Overexpression Service Product Offered &nbsp;11.3.3 Yuanjing Biology Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.3.4 Yuanjing Biology Main Business Overview &nbsp;11.3.5 Yuanjing Biology Latest Developments &nbsp;11.4 OBiO Technology &nbsp;11.4.1 OBiO Technology Company Information &nbsp;11.4.2 OBiO Technology Cell Gene Overexpression Service Product Offered &nbsp;11.4.3 OBiO Technology Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.4.4 OBiO Technology Main Business Overview &nbsp;11.4.5 OBiO Technology Latest Developments &nbsp;11.5 GENE &nbsp;11.5.1 GENE Company Information &nbsp;11.5.2 GENE Cell Gene Overexpression Service Product Offered &nbsp;11.5.3 GENE Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.5.4 GENE Main Business Overview &nbsp;11.5.5 GENE Latest Developments &nbsp;11.6 Brainvta &nbsp;11.6.1 Brainvta Company Information &nbsp;11.6.2 Brainvta Cell Gene Overexpression Service Product Offered &nbsp;11.6.3 Brainvta Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.6.4 Brainvta Main Business Overview &nbsp;11.6.5 Brainvta Latest Developments &nbsp;11.7 VectorBuilder &nbsp;11.7.1 VectorBuilder Company Information &nbsp;11.7.2 VectorBuilder Cell Gene Overexpression Service Product Offered &nbsp;11.7.3 VectorBuilder Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.7.4 VectorBuilder Main Business Overview &nbsp;11.7.5 VectorBuilder Latest Developments &nbsp;11.8 Boyuan Group &nbsp;11.8.1 Boyuan Group Company Information &nbsp;11.8.2 Boyuan Group Cell Gene Overexpression Service Product Offered &nbsp;11.8.3 Boyuan Group Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.8.4 Boyuan Group Main Business Overview &nbsp;11.8.5 Boyuan Group Latest Developments &nbsp;11.9 Horizo??n &nbsp;11.9.1 Horizo??n Company Information &nbsp;11.9.2 Horizo??n Cell Gene Overexpression Service Product Offered &nbsp;11.9.3 Horizo??n Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.9.4 Horizo??n Main Business Overview &nbsp;11.9.5 Horizo??n Latest Developments &nbsp;11.10 Creative Biogene &nbsp;11.10.1 Creative Biogene Company Information &nbsp;11.10.2 Creative Biogene Cell Gene Overexpression Service Product Offered &nbsp;11.10.3 Creative Biogene Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.10.4 Creative Biogene Main Business Overview &nbsp;11.10.5 Creative Biogene Latest Developments &nbsp;11.11 ACROBiosystems &nbsp;11.11.1 ACROBiosystems Company Information &nbsp;11.11.2 ACROBiosystems Cell Gene Overexpression Service Product Offered &nbsp;11.11.3 ACROBiosystems Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.11.4 ACROBiosystems Main Business Overview &nbsp;11.11.5 ACROBiosystems Latest Developments &nbsp;11.12 Cayegn &nbsp;11.12.1 Cayegn Company Information &nbsp;11.12.2 Cayegn Cell Gene Overexpression Service Product Offered &nbsp;11.12.3 Cayegn Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.12.4 Cayegn Main Business Overview &nbsp;11.12.5 Cayegn Latest Developments &nbsp;11.13 Creative Bioarray &nbsp;11.13.1 Creative Bioarray Company Information &nbsp;11.13.2 Creative Bioarray Cell Gene Overexpression Service Product Offered &nbsp;11.13.3 Creative Bioarray Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.13.4 Creative Bioarray Main Business Overview &nbsp;11.13.5 Creative Bioarray Latest Developments &nbsp;11.14 CUSABIO &nbsp;11.14.1 CUSABIO Company Information &nbsp;11.14.2 CUSABIO Cell Gene Overexpression Service Product Offered &nbsp;11.14.3 CUSABIO Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.14.4 CUSABIO Main Business Overview &nbsp;11.14.5 CUSABIO Latest Developments &nbsp;11.15 SBI &nbsp;11.15.1 SBI Company Information &nbsp;11.15.2 SBI Cell Gene Overexpression Service Product Offered &nbsp;11.15.3 SBI Cell Gene Overexpression Service Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.15.4 SBI Main Business Overview &nbsp;11.15.5 SBI Latest Developments 12 Research Findings and Conclusion

Report	Global Cell Gene Overexpression Service Market Growth (Status and Outlook) 2024-2030
Selected License	Multi ID: LPI15922

Buyer Information

Order Summary